Downregulation of CD40 Ligand Response in Monocytes from Sepsis Patients
- 1 December 2008
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 15 (12) , 1851-1858
- https://doi.org/10.1128/cvi.00184-08
Abstract
It has been suggested that a defective adaptive immune response contributes to septic immunosuppression. Here, the response of monocytes to CD40 ligand (CD40L) for patients with sepsis due to infection with gram-negative organisms has been analyzed. Compared to cells from controls, monocytes from septic patients showed significantly reduced production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-12 and were unable to acquire high levels of CD80 and CD86 molecules. These alterations were observed at the onset of sepsis and persisted at day 7. However, the ability of monocytes to respond to CD40L stimulation was partially but significantly restored in cells from patients who recovered from sepsis. In addition, costimulation of autologous CD4+ T lymphocytes by CD40L-activated monocytes from septic patients failed to induce cell proliferation and gamma interferon production. Finally, the ability of CD40L to rescue monocytes from apoptosis was severely impaired. We conclude that downregulation of the CD40L response may be an appropriate model for the monocyte alteration observed during septic immunosuppression and may help in the development of novel therapeutic strategies.Keywords
This publication has 55 references indexed in Scilit:
- Lipopolysaccharide desensitizes monocytes–macrophages to CD40 ligand stimulationImmunology, 2007
- Active Cytomegalovirus Infection in Patients with Septic ShockEmerging Infectious Diseases, 2006
- BACTERIAL CLEARANCE AND MORTALITY ARE NOT IMPROVED BY A COMBINATION OF IL-10 NEUTRALIZATION AND IFN-γ ADMINISTRATION IN A MURINE MODEL OF POST-CLP IMMUNOSUPPRESSIONShock, 2006
- CD40 Contributes to Lethality in Acute Sepsis: In Vivo Role for CD40 in Innate ImmunityInfection and Immunity, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Protection of Mice from Group A Streptococcal Skin Infection by Interleukin-12The Journal of Infectious Diseases, 1995
- T-LYMPHOCYTE Ca2+ SIGNALLING AND PROLIFERATIVE RESPONSES DURING SEPSISShock, 1994
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992